About the Company
We do not have any company description for enVVeno Medical Corp at the moment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
17
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on enVVeno Medical Corp
enVVeno Medical to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
PM ET IRVINE, CA / ACCESS Newswire / August 15, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company") ...
enVVeno Medical Corporation: Health Economic Study Shows That enVVeno Medical's VenoValve Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous ...
Clinical data and cost-effectiveness analysis demonstrates the VenoValve would provide both better health outcomes and lower costs compared to current standard of care treatmentsThe VenoValve could po ...
enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer
IRVINE, CA / ACCESS Newswire / May 19, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of deep ...
enVVeno Medical Participates in a New Virtual Investor “What This Means” Segment to Discuss How President Trump’s Recent CVI Diagnosis May Impact the Company
VVeno is developing the VenoValve as a potential treatment option for the approximately 2.5 million patients in the U.S. suffering from severe deep Chronic Venous Insufficiency – FDA decision expected ...
enVVeno Medical Reports Second Quarter 2025 Financial Results and ...
NVNO@jtcir.com (908) 824-0775 MEDIA CONTACT: Glenn Silver, FINN Partners Glenn.Silver@finnpartners.com (973) 818-8198 SOURCE: enVVeno Medical Corporation View the original press release on ACCESS ...
enVVeno Medical Participates in the Virtual Investor "What’s Your ...
NVNO@jtcir.com (908) 824-0775 MEDIA CONTACT: Glenn Silver, FINN Partners Glenn.Silver@finnpartners.com (973) 818-8198 SOURCE: enVVeno Medical Corporation View the original press release on ACCESS ...
enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Cash burn of $3.8 million in Q2 remains in line with projected quarterly range – Cash and investments are sufficient to fund operations through Q3’2026 at current cash burn rate – Commercial readiness ...
enVVeno Medical Reports Second Quarter 2025 Financial Results and ...
IRVINE, CA / ACCESS Newswire / August 1, 2025 / enVVeno Medical Corporation (NVNO) ("enVVeno Medical" or the "Company"), a company setting new standards of care for the treatment of deep venous ...
enVVeno Medical Reports Second Quarter 2025 Financial Results and ...
This press release and any statements of stockholders, directors, employees, representatives and partners of enVVeno Medical Corporation (the "Company") related thereto contain, or may contain ...
Similar Companies
Loading the latest forecasts...